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Abstract 
Background: Smoking, poor diet, and physical inactivity account for as much as 60% of cancer 
risk. Latinos experience profound disparities in health behaviors, as well as the cancers 
associated with them. Currently, there is a dearth of controlled trials addressing these health 
behaviors among Latinos. Further, to the best of our knowledge, no studies address all three 
behaviors simultaneously, are culturally sensitive, and are guided by formative work with the 
target population. Latinos represent 14% of the U.S. population and are the fastest growing 
minority group in the country. Efforts to intervene on these important lifestyle factors among 
Latinos may accelerate the elimination of cancer-related health disparities. 
Methods/Design: The proposed study will evaluate the efficacy of an evidence-based and 
theoretically-driven Motivation And Problem Solving (MAPS) intervention, adapted and 
culturally-tailored  for reducing cancer risk related to smoking, poor diet, and physical inactivity 
among high-risk Mexican-origin smokers who are overweight/obese (n = 400). Participants will 
be randomly assigned to one of two groups: Health Education (HE) or MAPS (HE + up to 18 
MAPS counseling calls over 18 months). Primary outcomes are smoking status, servings of 
fruits and vegetables, and both self-reported and objectively measured physical activity. 
Outcome assessments will occur at baseline, 6 months, 12 months, and 18 months. 
Discussion:  The current study will contribute to a very limited evidence base on multiple risk 
factor intervention studies on Mexican-origin individuals and has the potential to inform both 
future research and practice related to reducing cancer risk disparities. An effective program 
targeting multiple cancer risk behaviors modeled after chronic care programs has the potential 
to make a large public health impact because of the dearth of evidence-based interventions for 
Latinos and the extended period of support that is provided in such a program. 
Trial Registration. National Institutes of Health Clinical Trials Registry # NCT01504919. 
Keywords: Latinos, Mexican, Mexican American, smoking cessation, fruits/vegetables, 
physical activity 
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Background 
Over 60% of U.S. cancer mortality is attributable to tobacco use, poor nutrition, and 
physical inactivity [1, 2], with almost one-third of all cancers directly attributable to tobacco use 
alone. Smoking cessation is associated with decreased risk of lung cancer, other cancers, 
heart attack, stroke, and chronic lung disease [3]. Diet accounts for 35% of cancer deaths, with 
diets low in fat, and high in fruits, vegetables, fiber, and grain associated with reduced risk [4-
6]. A healthy diet is protective against lung, colon and rectum, breast, oral cavity, esophagus, 
stomach, pancreas, uterine cervix, and ovary cancer [7]. On the other side of the energy 
balance equation, regular physical activity can reduce the risk of colon and breast cancer [8-
10]. Additionally, balancing "energy in/energy out" (i.e., calories eaten vs. expended) is 
imperative to avoid weight gain and the increased risk of cancer and other chronic diseases 
associated with overweight and obesity. Excess body weight has been found to be related to 
increased risk of as many as 14 types of cancer [11]. Furthermore, these cancer risk factors 
tend to be clustered, with smokers particularly likely to be physically inactive and have poor 
diets [12-14]. The presence of multiple cancer risk factors has synergistic adverse effects on 
health [15]. Thus, strategies for addressing cancer risk reduction among high-risk individuals 
need to address these multiple health risk behaviors.  
The need for effective, culturally tailored behavior change interventions targeted at 
Latinos is critically important to public health for several reasons. First, Latinos, particularly of 
Mexican origin, are the fastest growing and largest minority group in the U.S. There are more 
than 40 million Latinos residing in the US, representing 14% of the total population [16], and 
people of Mexican origin account for 59% of this population [16]. Second, three of the four 
leading causes of death among Latinos [cancer, heart disease, and stroke; 17] share smoking, 
poor diet, and physical inactivity as risk factors. Third, there are notable disparities in these risk 
factors for the Latino population. For example, although the prevalence of smoking is lower 
among Latinos than among the general population [16% versus 21%; 18], Latinos who smoke 
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are less likely to receive advice to quit from a health professional, and to use cessation 
counseling services or medication compared to African American or White smokers [19]. 
National data indicate that 75% of Latinos do not eat the recommended servings of fruits and 
vegetables and 58% are physically inactive, with both Latino men and women being less likely 
to meet the recommended levels of fruits and vegetables and physical activity compared to non-
Hispanic Whites [20]. Fourth, there is a strong clustering of these risk factors among Latinos 
and disparities exist in this clustering relative to other racial/ethnic groups. Latino smokers have 
both the highest prevalence of overweight/obesity (79%) and the highest number of additional 
risk factors compared to African American or White smokers [21]. Finally, 43% of Latinos speak 
Spanish at home and have limited English proficiency, whereas another 36% speak 
predominantly Spanish at home [16]. Thus, cancer prevention efforts among Latinos should 
include Spanish language programs if they hope to have a large public health impact.  
Despite the critical importance of reducing cancer risk factors in Latinos, few stringent tests of 
targeted interventions have been conducted examining behavior change related to smoking 
cessation, diet or physical activity. For example, in contrast to the hundreds of smoking 
cessation treatment studies conducted among the general population [22], a recent review 
found only 12 studies that targeted Latino smokers [23]. Further, although all attended to 
cultural or linguistic tailoring to some extent, only five of those 12 studies utilized experimental 
designs. None of these studies attempted to simultaneously affect smoking and another health 
behavior. The situation is similar for diet and physical activity interventions among Latinos. A 
recent review found 16 culturally tailored interventions that examined behavioral outcomes (vs. 
knowledge/attitudes) and were tested with an experimental design [24].  Five of the 16 
examined only diet, two examined only physical activity, and eight examined both. One study 
examined smoking and fruit/vegetable consumption. Five of the 12 smoking interventions and 
12 of the 16 diet and physical activity interventions demonstrated significant effects. Thus, 
although notable efforts to create tailored or targeted interventions for Latinos have been made, 
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there continues to be a dearth of evidence-based interventions for interventions targeting 
multiple cancer risk behaviors. Interventions addressing multiple cancer risk factors have shown 
great promise, and there is evidence that attempts to change one risk factor often leads to 
interest in modifying other risk factors, reflecting potential synergies in changing overall cancer 
risk profiles [25-28]. In sum, there is a compelling public health need to develop behavior 
change interventions for Latinos that address multiple cancer risk factors. Further, the 
development and evaluation of behavior change interventions for Latinos and other underserved 
groups has been identified as a national health priority [22, 29].  
Study Objective and Aims 
The goal of this randomized controlled trial is to evaluate the efficacy of a telephone-
based counseling intervention that simultaneously addresses three cancer risk factors (smoking, 
fruit/vegetable consumption, physical activity) among overweight/obese Mexican-origin smokers 
in Houston, Texas. The intervention builds on previous work demonstrating the efficacy of the 
intervention for smoking cessation among Latinos of low socioeconomic status [SES; 30], and 
among female smokers [31], and efficacy in preventing postpartum smoking relapse among a 
diverse sample of low SES women [32]. Additionally, the intervention is informed by data 
demonstrating the feasibility of reaching Spanish-speaking Latinos in Texas via a telephone-
based intervention [30], and work demonstrating the efficacy of  telephone-based interventions 
for diet and physical activity [33, 34].  
The specific aims of the study are to: 1) Motivation and Problem Solving (MAPS) to 
promote and facilitate cancer risk reduction among high-risk Mexican-origin individuals 
(overweight/obese smokers). Relative to a Health Education (HE) condition, MAPS is 
hypothesized to result in positive changes in each of the primary smoking, diet, and physical 
activity outcomes, and; 2) assess the effects of MAPS on hypothesized treatment mechanisms 
(e.g., motivation, agency/self-efficacy, stress/affect) and their potential as treatment mediators.   
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Motivation And Problem Solving (MAPS) 
MAPS is a holistic, dynamic framework for behavior change that integrates treatment 
elements from both motivational interviewing [MI; 35, 36] and social cognitive theory [37, 38]. 
The overarching theoretical rationale for MAPS is the social cognitive model of behavior change 
[38, 39]. Social cognitive theory posits that “High levels of both motivation and self-efficacy are 
important ingredients … an individual may fail to engage in a specific behavior despite high 
levels of self-efficacy if the motivation for performance is low or absent” [38]. That is, theory 
posits that effective behavior change treatments require both enhancing the motivation to 
achieve and maintain change, as well as developing the self-efficacy and skills necessary to do 
so. Similarly, Miller et al. [40] note that “the key element for lasting change is a motivational shift 
that instigates a decision and commitment to change. In the absence of such a shift, skill 
training is premature." Nevertheless, current interventions often focus largely on either 
motivation (e.g., MI-based approaches) or problem-solving/skills training (e.g., social cognitive 
approaches) despite the strong theoretical and empirical bases for focusing on both. When 
motivation is addressed, the focus is typically on motivating individuals to initiate behavior 
change, with little to no focus on the motivation to maintain change or recover from a relapse 
[22]. 
MAPS embeds empirically validated social cognitive approaches within an overarching 
motivational enhancement framework based on MI. MI is a directive but client-centered 
therapeutic approach designed to minimize resistance, enhance motivation for change, and 
increase self-efficacy in a non-confrontational manner [35, 36]. Several meta-analyses have 
supported the efficacy of MI-based interventions for smoking, dietary behavior change, and 
physical activity [41-44]. MI has been found to be effective for promoting dietary change and 
physical activity, and our own research has demonstrated the efficacy of a motivational 
approach (MAPS) for smoking cessation [31, 32] including among Spanish speaking Latino 
smokers [30]. Similarly, the social cognitive model has generated a tremendous amount of 
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intervention research demonstrating that social cognitive treatments for smoking cessation, diet, 
and PA are effective [45, 46]. However, the relative neglect of motivation reduces their ability to 
effect behavior change among individuals who are not motivated to change.  
Further, although stage-based conceptualizations of behavior change emphasize both 
motivation and skills training, motivational shifts are conceptualized as relatively stable changes 
in “stage” [47]. In contrast, MAPS is relatively unique in that it conceptualizes motivation as a 
fluid construct that can fluctuate on a moment-to-moment basis depending on context. 
Counselors carefully assess and attend to changes in motivation so that treatment strategies 
are appropriately matched to motivation in the moment. MAPS utilizes a chronic care model 
(e.g., extended duration of treatment) and is built around a “wellness program” that in addition to 
focusing on cancer risk behaviors, also addresses life events, stressors, and other concerns 
(e.g., depression, family, financial, etc.). By addressing the larger context in which health 
behaviors occur, not only are many of the barriers for successful behavior change addressed, 
but adherence is increased because individuals perceive that the counselors care about them 
as whole people, and are not solely interested in their health behaviors.  
Major Hypothesized Mechanisms 
Both research and theory identify motivation, agency, and stress/negative affect as 
critical mechanisms underlying behavior change [48-51]. As such, MAPS specifically targets 
these mechanisms and they are hypothesized to underlie MAPS effects on behavior change. 
Motivation. A large body of evidence supports the role of motivation in the decision to 
change, the likelihood of change, and the maintenance of change. Motivation, measured in 
varying ways, predicts smoking quit attempts, smoking cessation success, dietary change, and 
change in physical activity [47, 52-55]. There is also evidence demonstrating that motivation can 
change rapidly [56-58], consistent with models positing that motivation is dynamic and 
characterized by frequent fluctuations [58]. Motivation for the maintenance of change has 
received little attention despite the fact that social cognitive theory posits that “The final and 
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most important stage of the change process is the maintenance stage. It is during the 
maintenance stage (which begins the moment after the initiation of abstinence or control) that 
the individual must work the hardest to maintain the commitment to change over time,” [38]. 
More specifically, the motivation for maintaining change may weaken and ambivalence may 
increase as the individual is exposed to temptations and stressors [38]. Therefore, MAPS 
includes a specific emphasis on motivation throughout the entire change process and on 
appropriate therapeutic responses to rapid fluctuations in motivation. In MAPS, the counselor 
continually attends to motivational cues and adjusts therapeutic strategies in response to even 
momentary changes in motivation. 
Agency (sense of control, self-efficacy). Human agency reflects the ability to intentionally 
affect one’s behavior or life situation. Agency is determined both by personal resources and by 
the contextual influences impinging on that individual [59]. Concepts encompassed under 
agency include sense of control and self-efficacy. Sense of control is a learned expectation that 
outcomes depend on personal choices and actions rather than on chance, other people, or 
forces outside one’s control [50, 60]. Self-efficacy is a form of agency that is context and 
behavior dependent; i.e., self-efficacy varies based on the behavior to be performed and 
situational demands [50, 51]. A greater sense of agency is reflected in greater self-efficacy 
when faced with situations that challenge one’s ability to initiate or maintain change. Self-
efficacy is a consistent predictor of behavior change in smoking, physical activity, and 
fruit/vegetable consumption [61-66]. Therefore, based on both data and social cognitive theory 
[38] MAPS targets agency via the removal of barriers to change, standard problem-solving and 
coping skills training, and by increasing motivation [38, 67, 68]. 
Stress/Negative Affect. Stress and negative affect, measured in many different ways, are 
associated with behavior change [69-71].  In addition, the magnitude and trajectory of 
stress/negative affect over time are powerful predictors of change [69, 70], as are individual 
differences in affective vulnerability.(95-98) Thus, MAPS includes stress management and 
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negative affect reduction strategies. 
MAPS Adaptation 
MAPS has demonstrated efficacy for smoking cessation among Spanish-speaking 
Latinos [30], to promote smoking quit attempts among women [31], and preventing  postpartum 
relapse [32]. Thus, the MAPS program must be adapted to additionally address fruit/vegetable 
consumption and physical activity. Consideration of the needs and preferences of the Mexican-
origin population in regards to fruit/vegetable consumption and physical activity must also be 
addressed during adaptation. Literature review, expert consultation, and focus groups with the 
target population will guide the adaptation. 
Literature Review.  A review of the published literature will be conducted with the goal of 
identifying shared barriers and facilitators of behavior in regards to fruit/vegetable consumption, 
physical activity, and smoking cessation. The purpose of this is to identify potential targets of 
intervention common to all three cancer risk behaviors that can be addressed through the 
MAPS intervention. Literature reviews will also be conducted with the goal of identifying 
practical models of cultural self-awareness and cross-cultural communication skills to 
encourage culturally sensitive counselor-participant interactions. 
Expert Consultation. Two researchers (authors EGE and KR) who are experts in 
motivational interventions for diet and physical activity are being consulted for the current study. 
The purpose of this is to gain expert feedback on the incorporation of these target behaviors into 
the MAPS intervention, which heretofore has been tested only with regard to smoking [30-32]. 
Focus Groups. Focus groups will be conducted to gain insights from the members of the 
target population on exercise and dietary habits, barriers, personal values, and the acceptability 
of program materials. Five focus groups will be conducted. Focus group participants must meet 
the same eligibility criteria as the randomized trial. A focus group guide is being developed with 
input from a subset of the study’s community advisory group that included questions about 
various elements of the interventions and materials. All recommendations for modifications to 
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the interventions and materials will be considered.   
Pilot Testing 
Following MAPS adaptation, the intervention and study procedures will be pilot tested on 
up to 20 individuals. Pilot testing will replicate the study procedures through approximately 2-3 
months post-baseline assessment. For evaluating the treatments, pilot procedures utilize the 
“technology model” developed by the Yale Psychotherapy Development Center [72]. Briefly, 
after developing a good working treatment protocol, the treatment is administered over a 
shortened timeframe to a small group of participants (typically about 5-7). The counselors and 
participants are extensively queried during this time as to the appropriateness, acceptability, 
usefulness, etc. of all materials, assessments, procedures, and counseling. Problems with the 
protocol usually become apparent fairly quickly and the protocol is then modified based on the 
feedback and a second round of pilot participants will be enrolled. After 2-3 cycles of pilot 
testing, the protocols are typically ready to be finalized. At that time, participants will be formally 
enrolled in the clinical trial. Pilot study participants will be compensated for assessments at a 
rate commensurate with the formal study participants. 
Methods/Design 
Location and Setting 
The study site will be the Behavioral Research and Treatment Center of The University 
of Texas MD Anderson Cancer Center. All baseline assessments, outcome assessments, and 
HE sessions will occur at this location. Additionally, individuals in the MAPS condition will 
receive telephone counseling based out of the Department of Health Disparities Research at 
The University of Texas MD Anderson Cancer Center. 
Ethics and Trial Registration 
The current study was funded by National Cancer Institute (NCI) Grant U54CA153505. 
The study was approved by the Institutional Review Board of The University of Texas MD 
Anderson Cancer Center (Protocol #: 2010-0606), and is registered on the National Institutes of 
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Health Clinical Trials Registry (available at ClinicalTrials.gov. Registration #: NCT01504919). 
Study Population and Eligibility 
The study population will be overweight or obese Spanish-speaking Mexican- or 
Mexican-origin smokers who reside in the Houston, Texas, metropolitan area. Inclusion criteria 
will be: 1) self-report of Mexican heritage; 2) age 18 or older; 3) current smoker with a history of 
smoking an average of at least one cigarette per day during the last year; 4) register an expired 
carbon monoxide level of at least five parts per million; 5) body mass index ≥ 25 based on 
measured height and weight; 6) ability to engage in low to moderate physical activity as 
determined by the Physical Activity Readiness Questionnaire [PAR-Q; 73]; 7) blood pressure 
reading <140/90 millimeters of mercury (mm Hg); 8) speak Spanish, and; 9) have a valid home 
address and a functioning telephone number. Participants do not need to be motivated to 
change their behavior.  
Participants with high blood pressure readings [defined as ≥ 140/90 mm Hg; 74] and 
those deemed ineligible based on the PAR-Q will be able to participate if they provide a letter 
from a physician who will continue to monitor the participant during the research study. 
Exclusion criteria include: 1) women who are pregnant or currently lactating; 2) contraindication 
for nicotine patch; 3) other active substance abuse or dependence; 4) regular use of other 
tobacco products; 5) current use of tobacco cessation medications; 6) currently enrolled in 
another study; 6) another household member enrolled in the study, and; 6) a score below 38 on 
the Short Assessment of Health Literacy for Spanish Adults [SAHLSA; 75]. Ineligible individuals 
will be given referrals to community resources. 
Recruitment 
Participants (N=400) will be recruited from the ongoing Mexican American Cohort Study 
(n > 20,000) in the Houston area and from the community. The Mexican American Cohort study 
was created in 2001 to assess genetic and non-genetic risk factors for cancer in this population. 
Recruitment procedures have been described in detail elsewhere [76].  Briefly, participants have 
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been recruited through multiple strategies, including random digit dialing, block walking in 
predominantly Mexican American neighborhoods (i.e., >75% based on 2000 U.S. Census), from 
community centers and health clinics, and networking through currently enrolled participants. 
Participants are contacted every 6 months to obtain updated health status and contact 
information. For this study, overweight/obese smokers will be identified from the study database 
and contacted by research staff to assess their interest in participating. Participants will 
additionally be recruited via radio and print advertisements and direct community outreach.  
Study Design 
The current study is a two-group randomized controlled trial designed to test the efficacy 
of MAPS versus HE for multiple cancer risk behaviors among Spanish-speaking Mexican-origin 
smokers. Figure 1 depicts the study flow. Potential participants will call a phone number 
dedicated to study recruitment. They will undergo an initial eligibility screening (including BMI 
and smoking status eligibility based on self-report). Those who pass the initial screening and 
choose to participate will be scheduled to attend an in-person visit at the study site. Additional 
screening will take place, including objective verification of height, weight, and smoking status. 
Participants will also be screened for health literacy. After completing additional screening, 
those who choose to participate will complete the baseline assessment and the first of three HE 
sessions. After completing the first HE session, participants will be randomly assigned to HE or 
MAPS.  
Randomization will occur using a form of adaptive randomization called minimization [77, 
78]. Compared to techniques such as stratification, minimization results in better group balance 
on participant characteristics. Minimization also provides for balanced treatment groups 
throughout the randomization process. Randomization will be balanced on gender, age, 
immigrant status, cigarettes per day, and BMI. 
 Individuals randomized to the MAPS condition will schedule their first counseling call 
during the baseline visit, and subsequently receive up to 18 counseling calls over an 18-month 
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period. Outcome assessments will occur at baseline, 6 months, 12 months, and 18 months. 
Also after completing the assessment and randomization procedures, the 6-month follow-up 
visit will be scheduled for all participants. Research staff conducting the outcome assessments 
will be blinded to participants’ treatment conditions. 
Control and Treatment Conditions 
HE Condition. HE will include three sessions of brief advice (10 minutes) regarding 
smoking cessation, diet, and physical activity change, including the provision of referrals to 
resources for behavior change (e.g., Texas Quitline, community diet and physical activity 
programs). Participants will also receive Spanish language self-help materials. Participants will 
be given a home-based exercise kit (e.g., pedometer, exercise ball, strength training cables) 
and related instruction on the use of the exercise kit’s content during the first HE session. When 
the participant informs research staff that s/he is ready to make a smoking cessation attempt, a 
6-week supply of free nicotine patches will be provided. HE will occur a total of 3 times (during 
the in-person assessment appointments at baseline, 6 months, and 12 months).   
MAPS Condition. The treatment condition will include HE plus up to 18 proactive, 
telephone-delivered MAPS counseling sessions over the 18-month period. Each counseling call 
will last approximately 20-30 minutes. Call frequency is negotiated between participant and 
counselor based on a participant’s motivation and needs. For example, several calls might be 
clustered around the initiation of a walking program, a smoking cessation attempt, holiday diet 
challenges, or specific barriers that the participant is facing (e.g., stress, lack of social support, 
family problems, financial crisis). Conversely, calls might be scheduled very infrequently when 
the participant is doing well. Regardless of when calls have been scheduled, participants are 
always able to call the study telephone line and request a counseling call.  
All participants will complete a Wellness Plan in collaboration with their MAPS counselor. 
The Wellness Plan is an organization of goals or areas of concern/importance that the 
participant wants to work on during counseling. Wellness Plan items may include change goals 
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for participants who are ready to make changes. The Wellness Plan may also include areas of 
concern or other topics that the participant would like to discuss where they may or may not be 
ready to change. Thus, the Wellness Plan will also be used in work with participants who are not 
motivated to make changes. This is because, although motivational enhancement will be the 
primary task being used in working with these participants, it may be helpful to list areas of 
concern or topics that the participant is simply willing to explore and revisit. Wellness Plan goals 
can include not only goals related to the target behaviors, but also a plan for addressing other 
salient concerns such as stress, interpersonal issues, family problems, etc. The Wellness Plan 
can also include plans for connecting participants with resources in the community to address 
their needs, such as vocational and educational training, and free or low cost childcare and 
medical treatment. The Wellness Plan is a central organizational component of counseling. 
Thus, although a participant can develop a Wellness Plan as early as the first few sessions, it is 
revisited and revised over time to reflect participants progression through the program or any 
new areas o f emphasis. 
MAPS is designed to tailor counseling sessions completely around the participant’s 
expressed readiness to change a target behavior, and their unique needs and preferences for 
coping skills. Thus, it is unlikely any two participants will progress through the program at the 
same pace or express/address identical concerns. However, the general progression is broadly 
organized as follows: Early MAPS counseling sessions (e.g., 1-5) are intended for introduction 
to the target behaviors and an assessment of the participant’s motivation to change any or all of 
smoking, fruit/vegetable consumption, and physical activity. Where the participant expresses 
readiness, Problem Solving/Skills Training techniques are utilized to facilitate change. Where 
the participant is not yet ready, a Motivational Interviewing approach is utilized. Later sessions 
(e.g., 7-16) are used either for continued motivational interviewing in the areas where the client 
expresses not being ready to change, action oriented counseling to facilitate change. or 
maintenance of change. Sessions 17 and 18 prepare the participant for ending the program and 
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include a final review of goals and progress, saying good-bye, and providing any additional 
necessary referrals. 
Counselor Qualifications, Calls, and Training. MAPS has been developed to be 
appropriate for delivery by lay and professional health workers. Counselors receive 
approximately 40 hours of MAPS training initially with “booster” sessions of approximately 1-2 
hours every 1-2 months during the study. Training continues until the counselor reaches 
competence and adherence criteria. Miscellaneous counseling issues are also discussed at 
weekly project meetings. This level of training and ongoing monitoring is consistent with the 
recommended level of training for real-world providers of health promotion interventions such as 
Quitline counselors [79] and ensures that MAPS is of the highest quality and follows the protocol 
precisely, both of which are key fidelity issues in evaluating new treatments. Counselors will be 
two Spanish-speaking members of the study staff who are experienced in the delivery of MAPS.  
Treatment Fidelity. To monitor drift, all calls are digitally recorded and encrypted. A 
random sample of 10% of calls are coded using a modified Motivational Interviewing Treatment 
Integrity Manual [MITI; 80]. The MITI has empirically validated reliability and validity, and is 
modified to include coding around appropriate social cognitive/problem-solving strategies, and 
transitions between the motivation building and problem-solving. Because MAPS utilizes a 
motivational interviewing framework, the MITI works well for ensuring adherence to the protocol 
and utilizing the general motivational interviewing spirit. A counselor who falls below 
performance criteria will receive additional training.  
Instruments 
 The majority of the assessment instruments have been previously used and validated in 
Spanish, or are being tested in our current research. Assessment instruments measure 
outcomes or hypothesized mechanisms. We attempted to reduce the inconvenience associated 
with completing the assessment battery by providing financial compensation for participants’ 
time and by using the Questionnaire Design System (QDS), a computer-administered self-
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interview format. The error and time necessary to complete an assessment battery are 
substantially reduced by using QDS and particularly so among individuals with low literacy 
because the computer can read each item in Spanish to the participants. Assessment 
procedures will be identical at each of the four visits, with the exception that only a subset of the 
demographic measures will be administered  at the 6, 12, and 18 month follow ups.  
Primary Outcomes 
Physical Activity 
International Physical Activity Questionnaire (IPAQ). The IPAQ assesses walking for 
exercise, walking for transportation, moderate and vigorous physical activity, and time spent 
sitting.  It is widely used to measure physical activity [73]. 
Accelerometer.  Participants will wear a small blinded accelerometer (i.e., participant 
cannot see values) over 7 days to assess PA. Accelerometers will be distributed at each 
assessment visit and will be returned via mail 
Fruit/Vegetable Consumption 
National Health Interview Survey Diet items. Items will be used to assess frequency of 
food intake in 16 broad categories to estimate intakes of fruits and vegetables, percentage 
energy from fat, and fiber diets [81]. 
Two-item Food Frequency Questionnaire. The two-item food-frequency questionnaire 
was developed to estimate intake of fruit and vegetables [82]. 
Smoking Abstinence 
Assessments will follow the recommendations from the Society for Research on Nicotine 
and Tobacco for cessation induction trials [83]. Participants will provide breath carbon monoxide 
to verify smoking. Although carbon monoxide has a relatively short half-life, the most 
comprehensive review on biochemical validation concluded that misreporting is typically very 
low (~2%) except for populations with substantial incentives to misreport (i.e., adolescents, 
pregnant women), and that adjustment for misreporting almost never influences analyses 
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regarding relative treatment efficacy [84]. Participants will also provide a saliva sample to verify 
smoking status.  The saliva sample will be provided at the baseline, 6 month, 12 month and 18 
month follow-up visits.  Saliva samples will be analyzed for cotinine, a metabolic byproduct of 
nicotine that provides an estimate of nicotine consumption.  A saliva cotinine level of <20 ng/ml 
will be considered as abstinent.   
Smoking Status Questionnaire.  This surveys tobacco use, use of other tobacco 
products, and nicotine replacement medications. The questionnaire also collects data on the 
use of other tobacco products and nicotine replacement medications as determined by the 
participant's time point in the protocol (e.g., based upon the date the participant quits 
smoking)[83]. 
Measures of Hypothesized Treatment Mechanisms 
Barriers Self-Efficacy Physical Activity.  The Barriers Self-Efficacy Physical Activity is a 
5-item measure on a five-point Likert-type and measures one’s confidence to meet a physical 
activity goal in the face of barriers to the behavior [85]. 
   Fruits and Vegetables Self-efficacy. The Fruits and Vegetables Self-efficacy is a 7-item 
measure on a 5-Likert scales.  Items assess family influences, decisional balances, and fruit 
and vegetable intake [85]. 
Fruits and Vegetables Staging. This is a 2-item measure of daily intake of fruits and 
vegetables and intent to change the current intake of fruit and vegetables. 
Motivation. Motivation to abstain from smoking  will be assessed with a 10-item scale 
currently being developed by our research team in order to assess motivation as a continuous 
variable as opposed to a stage. Items assess the motivation to quit smoking [86]. 
Positive and Negative Affect Scale (PANAS). The PANAS is comprised of two mood 
scales with high reliability, Positive Affect (PA) and Negative Affect (NA) [87].  
Self-Efficacy Scale. This is a 9-item scale reflecting the confidence of the individual that 
they can cope with high-risk situations without smoking [88]. 
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Smoking Self-Efficacy/Confidence.  The Smoking Self-Efficacy/Confidence scale 
assesses an individual's confidence to abstain from substance use or health behaviors in a 
variety of different situations. It consists of 9-item with 5 responses ranging from not at all 
confident to completely confident [88].   
Smoking Status Questionnaire. This surveys tobacco use, use of other tobacco 
products, and nicotine replacement medications. The questionnaire also collects data on the 
use of other tobacco products and nicotine replacement medications as determined by the 
participant's time point in the protocol (e.g., based upon the date the participant quits smoking) 
[83].  
Stages of Change: Physical Activity.  The Stages of Change: Physical Activity is a 1-item 
measure of the five stages of change in physical activity  [89]. 
Other Measures 
Brief Wisconsin Dependence Motives. This questionnaire yields an overall dependence 
score as well as subscale scores for other critical dimensions of tobacco dependence (affiliative 
attachment, automaticity, loss of control, cognitive enhancement, craving, cue 
exposure/associative processes, social/environmental goads, taste, tolerance, weight control, 
and affective enhancement). The overall and subscale scores have high internal consistencies 
and predict abstinence [90]. 
Demographics Questionnaire collects data on age, race, ethnicity, education, income, 
preferred language, and generations in the U.S. 
Medical History. Participants will be asked to provide a detail medical history including 
heart disease, asthma/lung disease, high blood pressure, diabetes, high cholesterol, thyroid 
problems, and kidney disease. 
Medication Worksheet.  Participants will be asked to provide a detail list of medications 
and their dosage that they take daily. 
Short Assessment of Health Literacy for Spanish Adults (SAHLSA). The SAHLSA will be 
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used to assess Spanish language health literacy. Participants are presented with a list of 50 
common medical terms. Each word is presented with a synonym and a distracter word. The 
participant is instructed to pronounce each word and identify the synonym. A score of 38 is 
indicative of at least marginal health literacy, and higher scores indicate greater health literacy 
[75]. 
Pharmacotherapy 
All study participants will have access to free nicotine patch therapy when they are ready 
to make a quit attempt. The provision of patch therapy or other cessation medication is the 
recommended standard of care. As such, it is arguably an ethical obligation to provide all 
participants with access to patch therapy. Study participants receive nicotine patch therapy 
because the patch is currently recognized as a frontline therapy [22], and compared to non-
nicotine medications such as bupropion or varenicline, the patch is safer, better tolerated, and 
available over the counter. Participants who decide to make a quit attempt will request patches 
by contacting project staff. Patches and instructions for their use will be distributed either via a 
visit to MD Anderson or via the mail. Patch therapy for participants who smoke >10 
cigarettes/day will consist of 4 weeks of 21 mg patches, 1 week of 14 mg patches, and 1 week 
of 7 mg patches. Patch therapy for participants who smoke 6-10 cigarettes/day will consist of 4 
weeks of 14 mg patches and 2 weeks of 7 mg  patches. Patch therapy for participants who 
smoke 1-5 cigarettes/day will consist of 6 weeks of 7 mg patches. A reduction in dosage or 
cessation of the patch regimen will be implemented for any participants who report signs of 
being on too high of a dose, although this is typically not necessary for participants because 
blood nicotine levels are usually far lower on the patch than while smoking [91]. In sum, all 
participants, regardless of treatment group assignment, will have the same access to nicotine 
patch therapy. We will carefully track pharmacotherapy use at all follow-up assessments. 
Participant Compensation and Retention 
To compensate for the time and inconvenience associated with participation, participants 
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will be reimbursed $25 for each of the 4 assessments (i.e., up to a total of $100). Focus group 
participants will receive a gift card worth $50. Pilot study participants will receive a $25 gift card 
at each visit (Day 1 and Month 3), for a total of up to $50 in gift cards. Participants will not 
receive compensation for the counseling calls. Other procedures to reduce attrition include: 1) 
mailing postcard reminders and calling to remind participants of upcoming visits; 2) maintaining 
communication with participants throughout the study via birthday cards, holiday cards, etc. 
(each mailing includes a stamped address update postcard to update contact information); 3) 
Having research staff member available during daytimes, evenings, and weekends to conduct 
study visits; 4) requiring that in addition to a functional phone number (necessary for counseling 
calls), participants have a home address so that they can be contacted by mail if necessary; and 
5) obtaining names, addresses, and phone numbers of up to three collaterals (i.e., 
relatives/friends) who can provide information on participants’ whereabouts during the study 
(permission to contact the collaterals will be obtained from participants). 
Data Analysis 
Primary outcomes used to evaluate the efficacy of the MAPS intervention (Aim 1) are  
smoking status, servings of fruits and vegetables, and both self-reported and objectively 
measured  physical activity (PA) assessed  at  the 6, 12, and 18 months.  Because the primary 
outcomes and mechanisms include repeated measurements that are correlated within subjects, 
the data analytic approach utilizes generalized linear mixed model regression [GLMM; 92, 93]. 
Model diagnostics will be used to determine and address the form of the covariances, 
transformations, collinearity, and influential observations. GLMM parameter tests will be 
conducted using Wald statistics, and will be adjusted for multiple comparisons where 
appropriate. Adjustments for multiple comparisons will be made according to the method of 
Westfall and Young [94]. In this approach, the correlations among the dependent variables are 
used to adjust the critical values of the individual tests to ensure that the probability of a Type I 
error across a set of tests does not exceed the chosen alpha level. This approach has the 
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advantage of maintaining the chosen Type I error rates while at the same time providing a less 
conservative adjustment than Bonferonni-type procedures.  
Aim 1. Evaluate the efficacy of a MAPS approach to promoting and facilitating reduction 
of behavioral risk factors for cancer among high-risk Mexican-origin individuals 
(overweight/obese smokers). Relative to Health Education, MAPS is hypothesized to result in 
positive changes in each of the primary smoking, diet, and PA outcomes. 
GLMM will be utilized in analyzing the effects of MAPS on the primary outcomes across 
the 6, 12, and 18-month time points. For the dichotomous outcome, we will assume a logit link 
and binomial variance function for the GLMM, and parameterize them with blocking on 
individual nested within treatment condition. Treatment and time will be included, as well as their 
interaction, with adjustment for relevant covariates as necessary. Time will be treated as a 
categorical variable. These models test for the main effects of treatment and time, and whether 
the treatment effect varies over time. For the continuous outcomes, the GLMM analysis will be 
replaced by linear mixed model (LMM) analysis (i.e., a special case of GLMM in which each 
outcome variable is continuous). 
Aim 2. Assess the effects of MAPS on hypothesized treatment mechanisms (e.g., 
motivation, agency/self-efficacy, stress/affect) and the role of those mechanisms in mediating 
the effect of MAPS on outcomes. 
To assess MAPS effects on treatment mechanisms, analyses largely analogous to the 
GLMM and LMM analyses described for Aim 1 will be conducted. Mediation will be indicated if: 
(a) there is a significant MAPS effect on the mechanism, and (b) the mechanism significantly 
predicts the outcome when adjusting for treatment. To formally test for the mediation effect, we 
will follow appropriate methods described by MacKinnon [95]. In particular, we will use a 
product-in-coefficient approach in which the indirect (mediation) effect is defined as the product 
of the coefficient of the intervention condition in the regression of the mechanism (a path) and 
the coefficient of the mechanism in the regression of the outcome variable controlling for 
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intervention condition (b path), with appropriate coefficient standardization from b path, when 
the outcome is binary [95]. This approach is applicable for both continuous and binary outcomes 
(e.g., smoking status, servings of fruits and vegetables, and both self-reported and objectively 
measured PA), with and without repeated measurements. We will use a bootstrapping approach 
to computing confidence intervals of the indirect effects. Multiple mediator models will be fit to 
assess simultaneous mediation effects by multiple mechanisms. In addition to the tests for 
indirect effects, we will also calculate proportion mediated effects and standard errors in both 
the simple and multiple mediator models.  
Missing Data and Drop-Outs. Some individuals will fail to complete all assessments. 
GLMM is designed to handle missing data and will give valid inferences for effects provided that 
the probability of missing data depends only on the observed outcome and/or covariates in the 
model (or data are missing at random or missing completely at random). We will conduct 
analyses to examine whether participants who drop out of the study differ from those who do 
not, and control for those characteristics that are unbalanced between dropouts and completers 
and believed to be associated with the outcomes. In case where non-ignorable dropout [96] is 
suspected, our primary analysis approach will use a conservative one of coding the missing 
outcome as a failure. For example, a missing smoking outcome could be coded as smoking. In 
addition, we will conduct sensitivity analysis using selection models to account for non-ignorable 
dropouts. Specifically, we will follow the approach of Diggle and Kenward [97] to model the 
dropout as a function of both the currently unobserved and previously observed values of the 
outcome variables (e.g., when dropout is due to lack of improvement in the outcome). 
Alternatively, we can consider a slope-dependent dropout mechanism [98, 99] to account for 
non-ignorable missingness. In this model, participants are believed to drop out with a high 
probability if the underlying (unobserved) rate of their change of outcome (e.g., PA level) over 
time is low. In spite of the availability of these potentially useful missing-data handling 
techniques, we do not expect they will lead to remarkably different results or conclusions given 
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our consistently high follow-up rates [30, 100-103]. 
Power 
All power analyses assume a significance level of 0.05 and a two-sided test and 
accounts for a potential 20% attrition at all time points (N=320; 160/group).  Three of the 
outcomes are continuous (servings of fruits and vegetables, METS of physical activity, 
accelerometer assessed activity). One outcome (smoking status) is dichotomous. Power is 
expected to be greater for intent-to-treat analyses than the power reported here, which 
represents completers only analyses. This is because the total number of cases for intent-to-
treat analyses will be 400, versus320 for the completers only analyses. For intent-to-treat 
analyses, those lost to follow up will be coded as not abstinent.  
Continuous outcomes. Because treatment outcomes are measured at 6, 12, and 18 
months, treatment effects may not be consistent across time points. In the case of a constant 
treatment effect across time, the detectable difference depends on the intraclass correlation 
coefficient (ICC) between measurements taken from a given participant. Since 160 participants 
per arm are assumed after attrition, and there are 3 measurements per participant, the effective 
sample size (ESS) per arm is 3*160/VIF, where VIF is the variance inflation factor 1 + (p-1)*ICC. 
In this formula, p is the average number of observations per participant. Table 2 shows the 
minimal detectable constant treatment effect under a range of values for the ICC when testing at 
a power of 80%. The detectable differences are given in terms of the standard deviation of the 
error term of the model. Thus, if the ICC is 0.3, the current study has 80% power to detect a 
shift of 0.229 standard deviations between the treatment arms, a small effect size per Cohen 
[104]. Power calculations displayed in Table 2 assume approximately consistent effects of 
treatment across measurements. However, correlations between more distal time points are 
generally lower than more proximal time points. Thus, calculations presented in Table 2 
represent a worst-case scenario. We further computed power for detecting an average 
intervention difference of 0.3 when the effect varies across time points, specifically, with a shift 
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of 0.1 at 6 months, 0.3 at 12 months, and 0.5 at 18 months. A Geisser-Greenhouse Corrected F 
Test was used for testing the intervention effect. The estimated power for detecting the 
treatment effect was 99%, 96%, and 91% for ICC values of 0.1, 0.3, and 0.5, respectively. It is 
important to note that the presented case of a 0.1, 0.3, and 0.5 increasing difference across 
time points produces exactly the same power as that of a 0.5, 0.3, and 0.1 decreasing 
difference across those time points.  
Binary outcomes. National data suggest that approximately 5% of the general population 
of smokers quit each year [105]. However, smokers in HE receive a brief treatment based on 
national recommendations [22]. Therefore, we estimate that the abstinence rate for HE will be 
approximately 5%, 10%, and 15% across the three follow-ups (i.e., 10% quit rate per year). 
Power calculations for correlated binary outcomes are more complex than continuous 
outcomes, which require simulations. For example, it is not possible to have the same ICC 
between all pairwise observations. Therefore, the mean of all pairwise ICC values was used as 
the overall ICC and looked at three potential scenarios based on the simulation of 1000 trials. 
Using the estimated quit rate for HE of 5%, 10%, and 15% across the three follow-ups, Table 3 
shows simulation results for constant, increasing, and decreasing differences between arms for 
each time point at ICC values of 0.1, 0.3, and 0.5. For cessation induction trials such as this 
one, the most likely scenario would be increasing differences over time given that 80-90% of 
smokers will not be motivated to quit at Baseline. Regardless, power is very good for detecting 
reasonable and meaningful differences between groups under realistic scenarios. 
Discussion 
Interventions addressing multiple cancer risk factors have shown great promise,  [25-27], 
and a variety of approaches and settings have been utilized to address multiple cancer risk 
factors. For example, both worksite and health center based multiple risk factor interventions 
have shown efficacy with respect to improving diet and PA, but smoking cessation results have 
generally not been as positive[25, 26, 106-109]. Overall, multiple risk factor interventions 
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provide an exceptionally promising and efficient means by which to facilitate behavior change 
and reduce cancer risk. Further, telephone-based interventions have demonstrated efficacy and 
broad reachas a method of of delivering smoking cessation, physical activity and diet/nutrition 
interventions [30-34]. The proposed study builds on this work using an intervention approach 
that has already been proven effective addressing smoking [30]. This intervention will be 
adapted, through literature review, expert consultation, and qualitative work, to simultaneously 
address smoking cessation, fruit/vegetable consumption, and physical activity, and to be 
sensitive to the needs of the target population. To the best of our knowledge, the current study 
will be among the first multiple risk factor intervention studies to focus on Mexican-origin 
individuals in general, and more specifically on overweight/obese Mexican-origin smokers, an 
extremely high risk group. 
MAPS combines two widely utilized and empirically validated approaches [36, 39] into a 
comprehensive, proactive, holistic approach that is specifically tailored to the motivational state, 
life concerns, and needs/preferences of the target population. MAPS is built around an 
individualized “wellness program” that is based on both successful chronic care models, patient 
navigation programs, and feedback from underserved communities. In addition to providing the 
necessary long-term support and strategies to initiate and maintain change, such an approach 
could potentially be more cost-effective than shorter interventions because of its effects on 
increasing the durability of treatment effects. Despite enthusiasm for more chronic care type 
approaches to behavior change, there have been few attempts to actually develop such 
programs. Moreover, telephone-based multiple risk factor counseling can both reduce the total 
number of risk factors, and be most effective among individuals with the greatest risk [i.e., 
among individuals with larger numbers of risk factors; 26]. Further, treating cancer risk factors 
within a chronic care model, as MAPS does, has the potential to boost long-term success rates 
by improving the ability of an intervention to promote motivation, aid change attempts, prevent 
relapse, and encourage recycling among individuals who are unsuccessful [110-113]. 
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Note: ICC = intraclass correlation coefficient; VIF = Variance Inflation Factor; ESS = Estimated 
Sample Size. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Minimal Detectable Difference with Constant Effect 
ICC VIF ESS Detectable Difference 
0.0 1.0 480 0.181 
0.1 1.2 400 0.198 
0.3 1.6 300 0.229 
0.5 2.0 240 0.256 
1.0 3.0 160 0.314 
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Table 2.  Simulation Results 
Constant Differences Increasing Differences Decreasing Differences 
 6 
months 
12 
months 
18 
months   
6 
months 
12 
months 
18 
months   
6 
months 
12 
months 
18 
months 
HE 0.05 0.10 0.15 HE 0.05 0.10 0.15 HE 0.05 0.10 0.15 
MAPS 0.15 0.20 0.25 MAPS 0.10 0.20 0.30 MAPS 0.20 0.20 0.20 
difference 0.10 0.10 0.10 difference 0.05 0.10 0.15 difference 0.15 0.10 0.05 
 
ICC power 95% CI ICC power 95% CI ICC power 95% CI 
0.10 0.99 0.98-1.00 0.10 0.99 0.98 1.00 0.10 0.99 0.98-1.00 
0.30 0.94 0.93-0.95 0.30 0.95 0.94 0.96 0.30 0.98 0.97-0.99 
0.50 0.79 0.76-0.82 0.50 0.84 0.82 0.86 0.50 0.98 0.97-0.99 
Note: HE = Health Education; MAPS = Motivation And Problem Solving; ICC = intraclass correlation coefficient; CI = 
confidence interval. 
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Figure 1. Study Flow 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruitment and 
Telephone 
Screen 
In-person screen, 
enrollment (if eligible), 
baseline assessment, 
first Health Education 
session, and 
randomization 
 
Up to18 MAPS 
Counseling 
Calls over 18 
months 
Health 
Education 
6-month follow-up 
assessment and 
second Health 
Education session 
12-month follow-up 
assessment and third 
Health Education 
session  
18-month follow-up 
assessment 
MAPS for Multiple Cancer Risk Behaviors   
 
 
Figure 1. Study Flow 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruitment and 
Telephone 
Screen 
In-person screen, 
enrollment (if eligible), 
baseline assessment, 
first Health Education 
session, and 
randomization 
 
Up to18 MAPS 
Counseling 
Calls over 18 
months 
Health 
Education 
6-month follow-up 
assessment and 
second Health 
Education session 
12-month follow-up 
assessment and third 
Health Education 
session  
18-month follow-up 
assessment 
Figure 1
Additional files provided with this submission:
Additional file 1: CNP design paper_abstract.docx, 15K
http://www.biomedcentral.com/imedia/1504451038919570/supp1.docx
Additional file 2: CNP design paper_title page.docx, 11K
http://www.biomedcentral.com/imedia/1434144112919570/supp2.docx
Additional file 3: CNP design paper_acknowledgements.docx, 14K
http://www.biomedcentral.com/imedia/1486218255919571/supp3.docx
